In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.
Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.
Researchers compared single-cell transcriptomic and epigenetic profiles of healthy blood cells and leukemia samples to find a role for RUNX1 in disease.
In Science this week: approach to visualize 3D genome structure in single cells, RNA interference knockdown screens to examine genetic origins of beetle horns and insect wings, and more.
The funding will be used to adapt the company's web-based genomic data analysis methods platform for computational analyses developed for ENCODE.
The trial aims to combine personal information, pharmacogenomics data, and machine-learning tools to select the best anti-seizure medication for patients.
Using ancient DNA, researchers retraced ancestral diversity and human migrations through Rome and central Italy going back more than 10,000 years.
The number of technologies to be assessed is vast, and ranges from liquid biopsies and molecular imaging to immunohistochemistry and RNA-seq.
By looking at genes and pathways with altered expression in tumor samples, researchers uncovered potential treatment targets beyond those provided by tumor DNA testing.
In Science this week: a review says lifestyles of industrialized societies may be threatening needed gut microbial communities, and more.
ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.
The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.
CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.